Post by
mercedesman on Dec 09, 2021 6:09pm
Here's a thought...
Maybe the company should set aside $ 1m of their $ 11M spare change...
Buy back 5 million shares at say . 20 to .25
Exhaust the "anonymous mystery tax loss seller"
Launch a "real" concerted US & Cdn IR /promo/marketing campaign.
Get the share price up to .50 to .75 range
Do a PP (if necessary) to replenish the coffers (although maybe not even required, if they found a SAMI Dist. partner, or a Dialco 10% eauity partner, or Baxter coughs up on Tranche 2, before Interim given open Label access to the "exceeding expectation" Tigris reults - at say 40 patients?, 50? 75?.
A lot less net dilution. More palatable SP. Happier shareholders.
It's a win win !
MM
Comment by
Revten on Dec 09, 2021 6:41pm
I agree MM! But in the meantime I am backing up the Truck Again!! Wow! This is getting very interesting! Thanks! Looking forward to January 2022!
Comment by
Domino55 on Dec 09, 2021 7:36pm
No thank you on a press release. This is Spectral. The result of that PR would be a dime share price. we know that they can masterfully oversee the destruction of market cap but who there, in the last 15 years, has managed an upward swing of a share price? Is there anyone there capable of managing significant buying pressure? They only have 1 direction on the payroll.
Comment by
BayStreetWild on Dec 09, 2021 8:18pm
That semi surprise financing was a bad move and the delay sucks but 50M market cap for a phase 3 pharma company is surreal. Unless there's some kind of meltdown in the background that we don't know about.... Maybe Seto does need to take out some sponsored BNN ads? They're not that expensive. 500 000 viewers would at least see the ad.